Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients
Julie O. Culver(City of Hope), Gregory Idos(City Of Hope National Medical Center), Rachel Hodan(Stanford Health Care), Meredith Mills(Cargill (Netherlands)), Alexandra Lebensohn(Stanford University), Courtney Rowe‐Teeter(Stanford University), Joseph D. Bonner(Michigan Medicine), Kerry Kingham(Cargill (Netherlands)), Katrina Lowstuter(University of Southern California), Katlyn Partynski(University of Southern California), Charité Ricker(University of Southern California), Caryn Lerman(Dartmouth College), Jennifer Morales Pichardo(City Of Hope National Medical Center), John Kidd(Myriad Genetics), Allison W. Kurian(Stanford University), Stephen B. Gruber(University of Southern California), Christine Hong(City Of Hope National Medical Center), Peter Levonian(Stanford University), Karlena Lara‐Otero(Stanford University), Uri Ladabaum(Stanford University), Nicolette M. Chun(Stanford University), Kevin McDonnell(City Of Hope National Medical Center), James M. Ford(Stanford University), Krystal Brown(Myriad Genetics), Duveen Sturgeon(City Of Hope National Medical Center)
Cited by 40
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
|Clinical Cancer Research|2016|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
|Nature Communications|2020|694